202 related articles for article (PubMed ID: 3926306)
21. Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns.
Bizanek R; Chowdary D; Arai H; Kasai M; Hughes CS; Sartorelli AC; Rockwell S; Tomasz M
Cancer Res; 1993 Nov; 53(21):5127-34. PubMed ID: 7693331
[TBL] [Abstract][Full Text] [Related]
22. Effects of mitomycin C and porfiromycin on exponentially growing and plateau phase cultures.
Rockwell S; Hughes CS
Cell Prolif; 1994 Mar; 27(3):153-63. PubMed ID: 10465006
[TBL] [Abstract][Full Text] [Related]
23. Potentiation of mitomycin C and porfiromycin antitumor activity in solid tumor models by recombinant human interleukin 1 alpha.
Braunschweiger PG; Jones SA; Johnson CS; Furmanski P
Cancer Res; 1991 Oct; 51(20):5454-60. PubMed ID: 1913664
[TBL] [Abstract][Full Text] [Related]
24. Activity of C-7 substituted cyclic acetal derivatives of mitomycin C and porfiromycin against hypoxic and oxygenated EMT6 carcinoma cells in vitro and in vivo.
Rockwell S; Keyes SR; Loomis R; Kelley M; Vyas DM; Wong H; Doyle TW; Sartorelli AC
Cancer Commun; 1991 Jun; 3(6):191-8. PubMed ID: 2049227
[TBL] [Abstract][Full Text] [Related]
25. Formation of a major DNA adduct of the mitomycin metabolite 2,7-diaminomitosene in EMT6 mouse mammary tumor cells treated with mitomycin C.
Palom Y; Belcourt MF; Kumar GS; Arai H; Kasai M; Sartorelli AC; Rockwell S; Tomasz M
Oncol Res; 1998; 10(10):509-21. PubMed ID: 10338154
[TBL] [Abstract][Full Text] [Related]
26. Failure of 5-thio-D-glucose to alter cell survival in irradiated or unirradiated EMT6 tumors.
Rockwell S; Schulz RJ
Radiat Res; 1984 Dec; 100(3):527-35. PubMed ID: 6505142
[TBL] [Abstract][Full Text] [Related]
27. Studies on the mechanism of the cytotoxic action of the mitomycin antibiotics in hypoxic and oxygenated EMT6 cells.
Sartorelli AC; Tomasz M; Rockwell S
Adv Enzyme Regul; 1993; 33():3-17. PubMed ID: 8356915
[TBL] [Abstract][Full Text] [Related]
28. Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual.
Marshall RS; Paterson MC; Rauth AM
Biochem Pharmacol; 1991 May; 41(9):1351-60. PubMed ID: 1902110
[TBL] [Abstract][Full Text] [Related]
29. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo.
Rauth AM; Mohindra JK; Tannock IF
Cancer Res; 1983 Sep; 43(9):4154-8. PubMed ID: 6409398
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
Kim SY; Rockwell S
Oncol Res; 1995; 7(5):39-47. PubMed ID: 8534933
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic attack of hypoxic cells of solid tumors: presidential address.
Sartorelli AC
Cancer Res; 1988 Feb; 48(4):775-8. PubMed ID: 3123053
[TBL] [Abstract][Full Text] [Related]
32. RSR13, a synthetic allosteric modifier of hemoglobin, as an adjunct to radiotherapy: preliminary studies with EMT6 cells and tumors and normal tissues in mice.
Rockwell S; Kelley M
Radiat Oncol Investig; 1998; 6(5):199-208. PubMed ID: 9822166
[TBL] [Abstract][Full Text] [Related]
33. Effect of 1-methyl-5-sulfonamide-4-nitroimidazole and 1-methyl-5-bromide-4-nitroimidazole on the radiosensitivity of EMT6 tumor cells.
Rockwell S; Irvin CG; Nierenburg M
Cancer Treat Rep; 1986 Mar; 70(3):411-3. PubMed ID: 3955554
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxic potential of monoalkylation products between mitomycins and DNA: studies of decarbamoyl mitomycin C in wild-type and repair-deficient cell lines.
Rockwell S; Kim SY
Oncol Res; 1995; 7(1):39-47. PubMed ID: 7549043
[TBL] [Abstract][Full Text] [Related]
35. Effect of hypoxia and acidosis on the cytotoxicity of four platinum complexes at normal and hyperthermic temperatures.
Herman TS; Teicher BA; Collins LS
Cancer Res; 1988 May; 48(9):2342-7. PubMed ID: 3356002
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxicity and DNA crosslinks produced by mitomycin analogs in aerobic and hypoxic EMT6 cells.
Keyes SR; Loomis R; DiGiovanna MP; Pritsos CA; Rockwell S; Sartorelli AC
Cancer Commun; 1991; 3(10-11):351-6. PubMed ID: 1760250
[TBL] [Abstract][Full Text] [Related]
37. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells.
Teicher BA; Kowal CD; Kennedy KA; Sartorelli AC
Cancer Res; 1981 Mar; 41(3):1096-9. PubMed ID: 7459853
[TBL] [Abstract][Full Text] [Related]
38. Hypoxic cell specific chemotherapeutic agents.
Sartorelli AC
Adv Enzyme Regul; 1982; 20():233-44. PubMed ID: 6810658
[TBL] [Abstract][Full Text] [Related]
39. In vitro toxicity to breast cancer cells of microsphere-delivered mitomycin C and its combination with doxorubicin.
Cheung RY; Rauth AM; Ronaldson PT; Bendayan R; Wu XY
Eur J Pharm Biopharm; 2006 Apr; 62(3):321-31. PubMed ID: 16330194
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis, and evaluation of mitomycin-tethered phosphorothioate oligodeoxynucleotides.
Huh N; Rege AA; Yoo B; Kogan TP; Kohn H
Bioconjug Chem; 1996; 7(6):659-69. PubMed ID: 8950485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
